Abraham, E. P. and Chain, E. An enzyme from bacteria able to destroy penicillin. Nature 1940; 146: 837.CrossRefGoogle Scholar

Angelin, M., Forsell, J., Granlund, M., et al. Risk factors for colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in healthcare students on clinical assignment abroad: a prospective study. Travel Med. Infect. Dis. 2015; 13(3): 223–9.Google Scholar

Ben-Ami, R., Rodriguez-Bano, J., Arslan, H., et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin. Infect. Dis. 2009; 49(5): 682–90.Google Scholar

Bush, K. and Fisher, J. F. Epidemiological expansion, structural studies, and clinical challenges of new beta-lactamases from gram-negative bacteria. Ann. Rev. Microbiol. 2011; 65: 455–78.CrossRefGoogle Scholar

Curello, J. and MacDougall, C. Beyond susceptible and resistant, part II: treatment of infections due to gram-negative organisms producing extended-spectrum beta-lactamases. J. Pediatr. Pharmacol. Ther. 2014; 19(3): 156–64.Google Scholar

Doi, Y., Park, Y. S., Rivera, J. I., et al. Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. Clin. Infect. Dis. 2013; 56(5): 641–8.Google Scholar

Falagas, M. E. and Karageorgopoulos, D. E. Extended-spectrum beta-lactamase-producing organisms. J. Hosp. Infect. 2009; 73(4): 345–54.Google Scholar

Garrec, H., Drieux-Rouzet, L., Golmard, J. L., et al. Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae. J. Clin. Microbiol. 2011; 49(3): 1048–57.Google Scholar

Hombach, M., Bloemberg, G. V., and Bottger, E. C. Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of gram-negative bacilli. J. Antimicrob. Chemo. 2012; 67(3): 622–32.Google Scholar

Kantele, A., Laaveri, T., Mero, S., et al. Antimicrobials increase travelers’ risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin. Infect. Dis. 2015; 60(6): 837–46.Google Scholar

Lin, J. N., Chen, Y. H., Chang, L. L., et al. Clinical characteristics and outcomes of patients with extended-spectrum beta-lactamase-producing bacteremias in the emergency department. Int. Emerg. Med. 2011; 6(6): 547–55.Google Scholar

Livermore, D. M. Defining an extended-spectrum beta-lactamase. Clin. Microbiol. Infect. 2008; 14(Suppl. 1): 3–10.CrossRefGoogle Scholar

Macdougall, C. Beyond susceptible and resistant, part I: treatment of infections due to gram-negative organisms with inducible beta-lactamases. J. Pediatr. Pharmacol. Ther. 2011; 16(1): 23–30.Google Scholar

National Nosocomial Infections Surveillance. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2002, issued August 2002. Am. J. Infect. Cont. 2002; 30(8): 458–75.CrossRefGoogle Scholar

Opal, S. M. and Medeiros, A. A. Molecular mechanisms of antibiotic resistance in bacteria in Bennett, J. E., Dolin, R., and Blaser, M. J. (eds.), Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edn. (Philadelphia, PA: Elsevier/Saunders, 2015), pp. 253–70.Google Scholar

Paterson, D. L. and Bonomo, R. A. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 2005; 18(4): 657–86.Google Scholar

Poirel, L. Fernandez, J., and Nordmann, P. Comparison of three biochemical tests for rapid detection of extended-spectrum β-lactamase-producing Enterobacteriaceae. J. Clin. Microbiol. 2016; 54(2): 423–7.Google Scholar

Roschanski, N., Fischer, J., Guerra, B., and Roesler, U. Development of a multiplex real-time PCR for the rapid detection of the predominant beta-lactamase genes CTX-M, SHV, TEM and CIT-type AmpCs in Enterobacteriaceae. PloS One. 2014; 9(7): e100956.CrossRefGoogle Scholar

Rottier, W. C., Ammerlaan, H. S., and Bonten, M. J. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J. Antimicrob. Chemo. 2012; 67(6): 1311–20.Google Scholar

Schwaber, M. J. and Carmeli, Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemo. 2007; 60(5): 913–20.Google Scholar

Sievert, D. M., Ricks, P., Edwards, J. R., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect. Cont. Hosp. Epidemiol. 2013; 34(1): 1–14.Google Scholar

Talan, D. A., Takhar, S. S., Krishnadasan, A., et al. Fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli infections in patients with pyelonephritis, United States. Emerg. Infect. Dis. 2016; 22(9): doi: 10.3201/eid2209.160148.CrossRefGoogle Scholar

Tangden, T., Cars, O., Melhus, A., and Lowdin, E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob. Agents Chemother. 2010; 54(9): 3564–8.Google Scholar

Wang, P., Hu, F., Xiong, Z., et al. Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints. J. Clin. Microbiol. 2011; 49(9): 3127–31.Google Scholar

Wolfensberger, A., Sax, H., Weber, R., et al. Change of antibiotic susceptibility testing guidelines from CLSI to EUCAST: influence on cumulative hospital antibiograms. PloS One. 2013; 8(11): e79130.CrossRefGoogle Scholar

Zumla, A., Al-Tawfiq, J. A., Enne, V. I., et al. Rapid point of care diagnostic tests for viral and bacterial respiratory tract infections – needs, advances, and future prospects. Lancet 2014; 14(11): 1123–35.CrossRefGoogle Scholar